Is Biologic Therapy an Effective Tool for Achieving Remission in Severe Asthma? A Retrospective Study in Central Romania.

Life (Basel) · 2025 · PMC12300431 · PMID 40724615

Europe PMC DOI

hedged sentences

0.0700

closest p · 1.4× alpha

0.0800

boldest claim

The sentences

approaching significancep = 0.07so close (0.05 < p ≤ 0.1)

The prevalence of type 2 diabetes was higher in the benralizumab group (29.4%) in comparison with the lack of prevalence in the other groups, approaching significance ( p = 0.07) ( Table 2 ).

also in 1,188 other papers

did not reach statistical significancep = 0.08so close (0.05 < p ≤ 0.1)

Among the biologic therapy groups, those receiving benralizumab were slightly older (median age: 68) than those taking dupilumab (65) and omalizumab (52), although the difference did not reach statistical significance ( p = 0.08).

also in 59,377 other papers

a positive trendno p-value reported

These patients demonstrate a positive trend, and there is optimism that they will be able to achieve asthma remission as a realistic therapeutic goal.

also in 5,754 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.